Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Actemra
Pharma
Fresenius Kabi launches US recall of Actemra biosimilar
Shortly after initiating a separate recall tied to mislabeled pain medicine, Fresenius Kabi is yanking a batch of another product in the U.S.
Fraiser Kansteiner
Aug 12, 2026 9:13am
J&J nixes Tremfya trial in giant cell arteritis
Jun 25, 2024 4:45pm
Roche, Biogen settle Actemra biosimilar lawsuit
Oct 25, 2023 10:20am
Takeda, Kyowa Kirin, Biogen—Fierce Pharma Asia
Oct 6, 2023 8:35am
Biogen nabs FDA nod for biosimilar of Roche blockbuster Actemra
Oct 2, 2023 10:42am
Roche sues Biogen over Actemra biosimilar infringement claims
Jul 17, 2023 9:45am